Share Zimmer Biomet raised its annual earnings and sales-growth outlook as hip implants and other products offset weaker knees. The price used for this comparison rose about 13% versus the previous close during trading on November 4.
$ZBH INSIGHTS →

zbh · signals · earnings · 5 min read · ♡ 37 · ▢ 0 · ↗ 0

Zimmer Biomet raised its annual earnings and sales-growth outlook as hip implants and other products offset weaker knees. The price used for this comparison rose about 13% versus the previous close during trading on November 4.

· App research preview · Editorial standards

Read the full research in the app

A subscription is required to access the full thread.

Open in the app →
Financials
Technicals